Simon C. Lowry
SVP, R&D, CMO, Emergent BioSolutions.
Companies
- Emergent BioSolutionsSVP, R&D, CMO Nov 21, 2024 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Emergent BioSolutions EBS177,914 shares2$1.2M at $6.46Apr 29, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Apr 29, 2026Granted 100,111 shares of Emergent BioSolutions2
- Mar 5, 2026Shares withheld for tax 10,636 shares at $8.44 of Emergent BioSolutions3
- Dec 14, 2025Shares withheld for tax 3,543 shares at $11.41 of Emergent BioSolutions4
- Mar 6, 2025Granted 62,500 shares of Emergent BioSolutions5
- Dec 15, 2024Granted 29,482 shares of Emergent BioSolutions6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGAREmergent BioSolutions, SVP, R&D, CMO
- 2
- 3SEC EDGARForm 4 filed Mar 5, 2026
- 4SEC EDGARForm 4 filed Dec 16, 2025
- 5SEC EDGARForm 4 filed Mar 10, 2025
- 6SEC EDGARForm 4 filed Dec 17, 2024